Searchable abstracts of presentations at key conferences in endocrinology

ea0011p326 | Diabetes, metabolism and cardiovascular | ECE2006

The effect of moxonodine on endothelial dysfunction in metabolic syndrome

Cikim Ayse Sertkaya , Topal Ergun , Cikim Kerim , Temel Ismail , Ozdemir Ramaza

Introduction: Metabolic syndrome (MS) is a clustering of risk factors. Endothelial dysfunction has been reported in patients with MS and even in healthy obese individuals with a normal metabolic profile. Sympathetic activity commonly is increased in obese hypertensives, and moxonidine, is found to be effective in lowering blood pressure and improving insulin sensitivity. The aim of this study is to evaluate the efficacy of moxonidine on endothelial dysfunction in insulin-resis...